These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17052140)

  • 1. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.
    Llabre MM; Weaver KE; Durán RE; Antoni MH; McPherson-Baker S; Schneiderman N
    AIDS Patient Care STDS; 2006 Oct; 20(10):701-11. PubMed ID: 17052140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART).
    Weaver KE; Llabre MM; Durán RE; Antoni MH; Ironson G; Penedo FJ; Schneiderman N
    Health Psychol; 2005 Jul; 24(4):385-392. PubMed ID: 16045374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.
    Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE
    Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.
    Farley J; Hines S; Musk A; Ferrus S; Tepper V
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):211-8. PubMed ID: 12794557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
    Merenstein D; Wang C; Gandhi M; Robison E; Levine AM; Schwartz RM; Weber KM; Liu C
    Complement Ther Med; 2012 Aug; 20(4):222-7. PubMed ID: 22579434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients.
    Garcia R; Badaró R; Netto EM; Silva M; Amorin FS; Ramos A; Vaida F; Brites C; Schooley RT
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1248-52. PubMed ID: 17209767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for and correlates of antiretroviral treatment interruptions in a cohort of patients from public and private clinics in southern India.
    Vallabhaneni S; Chandy S; Heylen E; Ekstrand M
    AIDS Care; 2012; 24(6):687-94. PubMed ID: 22107044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
    Walsh JC; Mandalia S; Gazzard BG
    AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.
    Farley JJ; Montepiedra G; Storm D; Sirois PA; Malee K; Garvie P; Kammerer B; Naar-King S; Nichols S;
    J Dev Behav Pediatr; 2008 Oct; 29(5):377-84. PubMed ID: 18714204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study.
    Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; Tuldrà A; Rovira T; Viladrich C; Bayés R; Burger DM; Negredo E; Clotet B;
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1166-75. PubMed ID: 17961100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results.
    Durante AJ; Bova CA; Fennie KP; Danvers KA; Holness DR; Burgess JD; Williams AB
    AIDS Care; 2003 Feb; 15(1):103-15. PubMed ID: 12655838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
    Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders.
    Parsons JT; Rosof E; Mustanski B
    AIDS Behav; 2008 Jan; 12(1):95-103. PubMed ID: 17503172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.